ECSP10010250A - METHODS FOR THE TREATMENT OF OBESITY AND DISEASES AND DISORDERS RELATED TO OBESITY - Google Patents

METHODS FOR THE TREATMENT OF OBESITY AND DISEASES AND DISORDERS RELATED TO OBESITY

Info

Publication number
ECSP10010250A
ECSP10010250A ECSP10010250A ECSP10010250A EC SP10010250 A ECSP10010250 A EC SP10010250A EC SP10010250 A ECSP10010250 A EC SP10010250A EC SP10010250 A ECSP10010250 A EC SP10010250A
Authority
EC
Ecuador
Prior art keywords
obesity
methods
treatment
diseases
disorders related
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Jonathan David Roth
Original Assignee
Amylin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc
Priority to ECSP10010250 priority Critical patent/ECSP10010250A/en
Publication of ECSP10010250A publication Critical patent/ECSP10010250A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describen métodos para el tratamiento de la obesidad o trastornos relacionados con la obesidad; estos métodos incluyen el uso de agentes antiobesidad dirigidos al cerebro anterior, en combinación con agentes antiobesidad dirigidos al cerebro posteriorMethods for the treatment of obesity or obesity-related disorders are described; These methods include the use of anti-obesity agents targeting the anterior brain, in combination with anti-obesity agents targeting the posterior brain.

ECSP10010250 2010-06-14 2010-06-14 METHODS FOR THE TREATMENT OF OBESITY AND DISEASES AND DISORDERS RELATED TO OBESITY ECSP10010250A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP10010250 ECSP10010250A (en) 2010-06-14 2010-06-14 METHODS FOR THE TREATMENT OF OBESITY AND DISEASES AND DISORDERS RELATED TO OBESITY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP10010250 ECSP10010250A (en) 2010-06-14 2010-06-14 METHODS FOR THE TREATMENT OF OBESITY AND DISEASES AND DISORDERS RELATED TO OBESITY

Publications (1)

Publication Number Publication Date
ECSP10010250A true ECSP10010250A (en) 2011-01-31

Family

ID=44279981

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP10010250 ECSP10010250A (en) 2010-06-14 2010-06-14 METHODS FOR THE TREATMENT OF OBESITY AND DISEASES AND DISORDERS RELATED TO OBESITY

Country Status (1)

Country Link
EC (1) ECSP10010250A (en)

Similar Documents

Publication Publication Date Title
CY1124307T1 (en) PHARMACEUTICAL COMPOSITION, METHODS OF THERAPY AND USES THEREOF
EA201391154A2 (en) METHODS AND COMPOSITIONS FOR ADISCING TO ADIPOCYTES IN MAMMALS
GT201400057A (en) 3-PIRMIDIN-4-IL-OXAZOLIDIN-2-ONAS AS INHIBITORS OF THE MUTANT HDI
BR112018000691A2 (en) interleukin-23 receptor peptide inhibitors and their use to treat inflammatory diseases
BR112015020389A2 (en) carbazole compounds useful as bromodomain inhibitors
DOP2013000036A (en) CYCLLOBUTAN DERIVATIVES AS JAK INHIBITORS
WO2014145159A3 (en) Charge-engineered antibodies or compositions of penetration-enhanced targeting proteins and methods of use
UY35682A (en) ANTI-ACTIVINE ANTIBODIES A AND USES OF THE SAME
ECSP12012326A (en) AMINOPIRIMIDINE DERIVATIVES AS MODULATORS OF THE LRRK2
MX343687B (en) Tricyclic sulfonamide compounds and methods of making and using same.
ECSP12012211A (en) COMPOSITIONS OF ANTI-FACTOR ANTI-FACTOR OF NERVOUS GROWTH (NGF)
EA201270767A1 (en) THERAPY ON THE BASIS OF LIGANDS OF CHEMOSENSOR RECEPTORS
UY34278A (en) NEW NOXEDINE DERIVATIVES OF OXAZINE AND ITS USE IN THE TREATMENT OF DISEASES
UY33865A (en) Novel Heterocyclic Derivatives and their Use in the Treatment of Neurological Disorders
EA201201201A1 (en) NEW ROCK INHIBITORS
EA201590343A1 (en) ALKYLPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES
BR112014020826A2 (en) modulators and methods of use
MX2015011445A (en) Compounds and uses thereof for the modulation of hemoglobin.
EA201270722A1 (en) RIFAXIMINE FORMS AND THEIR APPLICATION
BR112015029386A2 (en) use of eribulin and lenvatinib as combination therapy for cancer treatment
MY180626A (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
BRPI1013698A2 (en) methods for treatment with the use of combination therapy
HRP20180575T1 (en) CERVICAL CUSHION FOR THE TREATMENT OF DISEASES OF THE CIRCULAR DISEASE
BR112014030406A2 (en) combination of phytocannabinoid cannabidiol with therapeutic hypothermia
ECSP11010956A (en) COMPOUNDS LINKED WITH SULFUR FOR THE TREATMENT OF DISEASES AND OPHTHALMIC DISORDERS